Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has identified its current COO, Dr Juho Jalkanen, as the best candidate to replace existing CEO, Dr Markku Jalkanen, who will retire from his position…
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has identified its current COO, Dr Juho Jalkanen, as the best candidate to replace existing CEO, Dr Markku Jalkanen, who will retire from his position…
…
…